depression treatment Archives

Diamond Lake Clinic’s EXOMIND rollout signals shifting priorities in noninvasive depression treatment

By Pallavi Madhiraju on February 14, 2026 Medical Devices & Diagnostics

Diamond Lake Clinic introduces EXOMIND for depression care. Find out what this shift means for neuromodulation, evidence standards, and mental health treatment models.

Can ketamine treatment clinics like Serenity redefine psychiatric care delivery in suburban America?

By Pallavi Madhiraju on January 20, 2026 Pharma & Biotech

Serenity expands ketamine therapy in Florida. Find out how this signals a shift in psychiatric care access and what clinicians are watching next.

Elunetirom shows synaptogenic promise as Autobahn eyes pivotal trials in depression

By Pallavi Madhiraju on January 17, 2026 Pharma & Biotech

Autobahn’s elunetirom may offer a novel neuroplasticity-driven treatment for depression. Find out what its latest data mean for the future of MDD therapy.